Financings in Brief: Bioject
This article was originally published in The Gray Sheet
Executive Summary
Bioject: Raises $2 mil. in gross proceeds from a private placement of common stock and warrants. Portland, Oregon-based Bioject, which is developing needle-free injection systems for intramuscular and subcutaneous drug delivery, issued 3.1 mil. shares of common stock and warrants to purchase another 3.1 mil. common shares...